PIK3CD and neoplasm: Using Akt phosphorylation as a readout for PI3K activity, we observed that both p110α-deficient and p110α/PTEN-deficient tumors cells displayed sensitivity to p110β inhibition, whereas, wild-type tumor cells displayed constant levels of p-Akt.